Skip to main content
. 2018 Dec 12;18:232. doi: 10.1186/s12872-018-0959-1

Table 1.

Baseline characteristics of HF patients, MAHFER study

N = 195
Characteristic
 Age, mean (SD), years 52 (21.4)
 Women, n (%) 132 (67.7)
 Asset index quintiles, n (%)
  Poorest 33 (16.9)
  Poorer 32 (16.4)
  Average 34 (17.4)
  Rich 38 (19.5)
  Richest 34 (12.3)
  Missing 24 (12.3)
 Highest education level attained, n (%)
  None 73 (37.4)
  Primary 105 (53.9)
  Secondary & Tertiary 17 (8.7)
 Smoking history, n (%)
  Never smoked 153 (78.5)
  Former smoker 24 (12.3)
  Current smoker 18 (9.2)
 Alcohol use history, n (%)
  Never 19 (9.7)
  Non-hazardous 172 (88.2)
  Hazardous 4 (2.1)
Comorbid diseases
 Hypertension, n (%) 56 (28.7)
 Diabetes mellitus, n (%) 15 (7.7)
 HIV infection, n (%) 16 (8.2)
 None 108 (55.4)
 Self-reported poor medication adherence 115 (59)
Aetiology of Heart failure
 Hypertensive heart disease 42 (21.5)
 Dilated cardiomyopathies 39 (20.0)
 Ischemic heart disease 6 (3.1)
 Unknown 108 (55.4)
NYHA¥ functional class at enrollment
 NYHA class I, n (%) 0 (0)
 NYHA class II, n (%) 1 (0.5)
 NYHA class III, n (%) 85 (43.6)
 NYHA class IV, n (%) 109 (55.9)
Left ventricular ejection fraction (LVEF)
 LVEF*, mean (SD) 41 (12.9)
Medication during hospital stay*, n (%)
 Furosemide 178 (91.3)
 ACEI/ARB 54 (27.7)
 Digoxin 45 (23.1)
 Dobutamine 20 (10.3)
Blood test
 Blood urea nitrogen (mg/dL), mean (SD) 59.6 (65.4)
 Serum Creatinine (mg/dL), mean (SD) 2.0 (2.7)
 Serum sodium (mmol/L), mean (SD) 132 (15.8)
 BNP(pg/mL), mean (SD) 2164 (1762)
 CKMB (ng/mL), mean (SD) 4.3 (10.2)

SD standard deviation, NYHA¥ New York Heart Association, LVEF* Left ventricular Ejection fraction, HIV Human Immunodeficiency virus, ACEI/ARB Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker, BNP Brain Natriuretic Peptide, CKMB Creatine-Kinase (MB isomer)

*Most participants took multiple medications thus the percentages of medications add up to more than 100%